LIPINUTRAGEN
Launch date
Company register number BO0452721
Bologna Emilia-Romagna (HQ)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | <1m | <1m |
| % growth | (10 %) | 45 % | (30 %) | (8 %) | (27 %) | 32 % | (15 %) |
| EBITDA | <1m | <1m | <1m | <1m | - | <1m | (<1m) |
| % EBITDA margin | 11 % | 14 % | 7 % | 5 % | - | 6 % | (12 %) |
| Profit | <1m | <1m | <1m | (<1m) | (<1m) | (<1m) | (<1m) |
| % profit margin | 3 % | 8 % | 1 % | (2 %) | (52 %) | (3 %) | (18 %) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
€80.0k | Grant | ||
| Total Funding | $88.0k | ||
Related Content
Recent News about LIPINUTRAGEN
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.